‡ Reporting is enabled for pathogenic germline alterations only. Somatic alterations will not be reported.¹

§ Reporting is enabled for both germline and somatic alterations. Alterations reported may include somatic (not inherited) or germline (inherited) alterations. The assay filters germline variants from reporting except for pathogenic BRCA1, BRCA2, ATM, and CDK12 alterations. However, if a reported alteration is suspected to be germline, confirmatory testing should be considered in the appropriate clinical context. The test is not intended to replace germline testing or to provide information about cancer predisposition.¹